Peripheral dual-energy X-ray absorptiometry in the management of osteoporosis: The 2007 ISCD Official Positions

被引:61
作者
Hans, Didier B. [1 ]
Shepherd, John A. [2 ]
Schwartz, Elliott N. [3 ]
Reid, David M. [4 ]
Blake, Glen M. [5 ]
Fordham, John N. [6 ]
Fuerst, Thomas [7 ]
Hadji, Peyman [8 ]
Itabashi, Akira [9 ]
Krieg, Marc-Antoine
Lewiecki, E. Michael [10 ]
机构
[1] Univ Hosp Geneva, Geneva, Switzerland
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] No Calif Inst Bone Hlth, Oakland, CA USA
[4] Univ Aberdeen, Aberdeen, Scotland
[5] Guys Hosp, London SE1 9RT, England
[6] James Cook Univ Hosp, Middlesbrough, England
[7] Synarc Inc, San Francisco, CA USA
[8] Univ Marburg, Marburg, Germany
[9] Saitama Med Sch, Moroyama, Saitama 35004, Japan
[10] New Mexico Clin Res & Osteoporosis Ctr, Albuquerque, NM USA
关键词
diagnosis; finger BMD; forearm BMD; fractures; heel BMD; osteoporosis; pDXA;
D O I
10.1016/j.jocd.2007.12.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peripheral assessment of bone density using photon absorptiometry techniques has been available for over 40 yr. The initial use of radio-isotopes as the photon source has been replaced by the use of X-ray technology. A wide variety of models of single- or dual-energy X-ray measurement tools have been made available for purchase, although not all are still commercially available. The Official Positions of the International Society for Clinical Densitometry (ISCD) have been developed following a systematic review of the literature by an ISCD task force and a subsequent Position Development Conference. These cover the technological diversity among peripheral dual-energy X-ray absorptiometry (pDXA) devices; define whether pDXA can be used for fracture risk assessment and/or to diagnose osteoporosis; examine whether pDXA can be used to initiate treatment and/or monitor treatment; provide recommendations for pDXA reporting; and review quality assurance and quality control necessary for effective use of pDXA.
引用
收藏
页码:188 / 206
页数:19
相关论文
共 91 条
[1]   Efficient patient identification strategies for women with osteoporosis [J].
Abbott, TA ;
Mucha, L ;
Manfredonia, D ;
Schwartz, EN ;
Berger, ML .
JOURNAL OF CLINICAL DENSITOMETRY, 1999, 2 (03) :223-230
[2]  
Adebajo A, 2006, Nurs Stand, V20, P35
[3]   Forearm bone density in users of Depo-Provera as a contraceptive method [J].
Bahamondes, L ;
Perrotti, M ;
Castro, S ;
Faúndes, D ;
Petta, C ;
Bedone, A .
FERTILITY AND STERILITY, 1999, 71 (05) :849-852
[4]   A prospective study of the forearm bone density of users of etonorgestrel- and levonorgestrel-releasing contraceptive implants [J].
Bahamondes, L ;
Monteiro-Dantas, C ;
Espejo-Arce, X ;
Fernandes, AMD ;
Lui-Filho, JF ;
Perrotti, M ;
Petta, CA .
HUMAN REPRODUCTION, 2006, 21 (02) :466-470
[5]   Can peripheral DXA measurements be used to predict fractures in elderly women living in the community? [J].
Barr, RJ ;
Adebajo, A ;
Fraser, WD ;
Halsey, JP ;
Kelsey, C ;
Stewart, A ;
Reid, DM .
OSTEOPOROSIS INTERNATIONAL, 2005, 16 (10) :1177-1183
[6]   Osteoporosis and fracture risk in women of different ethnic groups [J].
Barrett-Connor, E ;
Siris, ES ;
Wehren, LE ;
Miller, PD ;
Abbott, TA ;
Berger, ML ;
Santora, AC ;
Sherwood, LM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (02) :185-194
[7]   The Tromso study: Artifacts in forearm bone densitometry prevalence and effects [J].
Berntsen, GKR ;
Tollan, A ;
Magnus, JH ;
Sogaard, AJ ;
Ringberg, T ;
Fonnebo, V .
OSTEOPOROSIS INTERNATIONAL, 1999, 10 (05) :425-432
[8]   The Tromso Study: Determinants of precision in bone densitometry [J].
Berntsen, GKR ;
Fonnebo, V ;
Tollan, A ;
Sogaard, AJ ;
Joakimsen, RM ;
Magnus, JH .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2000, 53 (11) :1104-1112
[9]   Official positions of the International Society for Clinical Densitometry and executive summary of the 2005 Position Development Conference [J].
Binkley, Neil ;
Bilezikian, John P. ;
Kendler, David L. ;
Leib, Edward S. ;
Lewiecki, E. Michael ;
Petak, Steven M. .
JOURNAL OF CLINICAL DENSITOMETRY, 2006, 9 (01) :4-14
[10]   The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis [J].
Black, DM ;
Greenspan, SL ;
Ensrud, KE ;
Palermo, L ;
McGowan, JA ;
Lang, TF ;
Garnero, P ;
Bouxsein, ML ;
Bilezikian, JP ;
Rosen, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (13) :1207-1215